Keywords: USA, FDA, Generic Plavix, Clopidogrel, Mylan, Dr Reddy's

US FDA approves generic versions of blood thinner Plavix

Article | 18 May 2012

Coinciding with the loss of patent protection on Sanofi (Euronext: SAN) and Bristol-Myers Squibb’s (NYSE: BMY) blockbuster blood ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in